Search JIM Advanced Search

Journal of Chinese Integrative Medicine ›› 2013, Vol. 11 ›› Issue (4): 233-240.doi: 10.3736/jintegrmed2013037

Special Issue: Traditional Chinese Medicine

• Review •     Next Articles

Research advances on the usage of traditional Chinese medicine for neuroprotection in glaucoma

Xue-song Mia,b, Jing-xiang Zhonga, Raymond Chuen-Chung Changb,c, Kwok-Fai Sob,c()   

  1. a. Department of Ophthalmology, the First Affiliated Hospital, Jinan University, Guangzhou 510630,Guangdong Province, China
    b. Department of Anatomy, and the State Key Laboratory of Brain and Cognitive Science, Li Ka ShingFaculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong, China
    c. Guangdong-Hong Kong-Macau Institute of Central Neural System Regeneration, Jinan University,Guangzhou 510630, Guangdong Province, China
  • Received:2013-01-30 Accepted:2013-04-08 Online:2013-07-10 Published:2013-07-15

Progressive loss of retinal ganglion cells (RGCs) and their axons is the main pathogenesis of glaucoma. The cause of glaucoma is not fully understood, but the neurodegeneration of glaucoma involves many mechanisms such as oxidative stress, glutamate toxicity and ischemia/reperfusion insult. In order to target these mechanisms, multiple neuroprotective interventions have been investigated to prevent the death of RGCs. Of note are some tonic herbs from the traditional Chinese medicine (TCM) pharmacopeia that have shown neuroprotective effects in glaucoma. TCM differs from Western medicine in that TCM exhibits complicated bioactive components, triggering many signaling pathways and extensive actions on vital organs. Modern scientific approaches have demonstrated some of their underlying mechanisms. In this review, we used Lycium barbarum and Ginkgo biloba as examples to elaborate the characteristics of TCM and their potential applications in neuroprotection in glaucoma.

Key words: Neuroprotection, Neuroprotective agents, Traditional Chinese medicine, Glaucoma, Review

Figure 1

Neurovascular dysregulation and neuroprotective mechanisms of LBP When challenged by external stress or insult, LBP protected RGCs directly by reducing the cytotoxicity on RGCs (ET-1 and Aβ), and indirectly by inhibiting the damage of BRB and modulating retinal gliosis. LBP: polysaccharide of Lycium barbarum; RGCs: retinal ganglion cells; ET-1: endothelin-1; Aβ: amyloid-β; BRB: blood retinal barriers."

[1] Foster PJ, Johnson GJ . Glaucoma in China: how big is the problem? Br[J] Ophthalmol. 2001; 85(11):1277-1282.
[2] Quigley HA . Glaucoma[J]. Lancet, 2011,377(9774):1367-1377
doi: 10.1016/S0140-6736(10)61423-7
[3] Quigley HA . Clinical trials for glaucoma neuroprotection are not impossible[J]. Curr Opin Ophthalmol, 2012,23(2):144-154
doi: 10.1097/ICU.0b013e32834ff490
[4] McKinnon SJ . Glaucoma: ocular Alzheimer’s disease[J]. Front Biosci, 2003,8:s1140-s1156
doi: 10.2741/1172
[5] Flammer J, Orgül S, Costa VP, Orzalesi N, Krieglstein GK, Serra LM, Renard JP, Stefánsson E . The impact of ocular blood flow in glaucoma[J]. Prog Retin Eye Res, 2002,21(4):359-393
doi: 10.1016/S1350-9462(02)00008-3
[6] Vingrys AJ . The many faces of glaucomatous optic neuropathy[J]. Clin Exp Optom, 2000,83(3):145-160
doi: 10.1111/cxo.2000.83.issue-3
[7] Almasieh M, Wilson AM, Morquette B, Cueva Vargas JL, Di Polo A . The molecular basis of retinal ganglion cell death in glaucoma[J]. Prog Retin Eye Res, 2012,31(2):152-181
doi: 10.1016/j.preteyeres.2011.11.002
[8] Chader GJ . Advances in glaucoma treatment and management: neurotrophic agents[J]. Invest Ophthalmol Vis Sci, 2012,53(5):2501-2505
doi: 10.1167/iovs.12-9483n
[9] Nakatani M, Shinohara Y, Takii M, Mori H, Asai N, Nishimura S, Furukawa-Hibi Y, Miyamoto Y, Nitta A . Periocular injection of in situ hydrogels containing Leu-Ile, an inducer for neurotrophic factors, promotes retinal ganglion cell survival after optic nerve injury[J]. Exp Eye Res, 2011,93(6):873-879
doi: 10.1016/j.exer.2011.09.024
[10] Parrilla-Reverter G, Agudo M, Sobrado-Calvo P, Salinas-Navarro M, Villegas-Pérez MP, Vidal-Sanz M . Effects of different neurotrophic factors on the survival of retinal ganglion cells after a complete intraorbital nerve crush injury: a quantitative in vivo study. Exp Eye Res; 2009; 89(1):32-41.
doi: 10.1016/j.exer.2009.02.015
[11] Wen R, Tao W, Li Y, Sieving PA . CNTF and retina[J]. Prog Retin Eye Res, 2012,31(2):136-151
doi: 10.1016/j.preteyeres.2011.11.005
[12] Zhou X, Xia XB, Xiong SQ . Neuro-protection of retinal stem cells transplantation combined with copolymer-1 immunization in a rat model of glaucoma[J]. Mol Cell Neurosci, 2013,54:1-8
doi: 10.1016/j.mcn.2012.12.001
[13] Harper MM, Grozdanic SD, Blits B, Kuehn MH, Zamzow D, Buss JE, Kardon RH, Sakaguchi DS . Transplantation of BDNF-secreting mesenchymal stem cells provides neuroprotection in chronically hypertensive rat eyes[J]. Invest Ophthalmol Vis Sci, 2011,52(7):4506-4515
doi: 10.1167/iovs.11-7346
[14] Dreyer EB, Zurakowski D, Schumer RA, Podos SM, Lipton SA . Elevated glutamate levels in the vitreous body of humans and monkeys with glaucoma[J]. Arch Ophthalmol, 1996,114(3):299-305
doi: 10.1001/archopht.1996.01100130295012
[15] Giulian D . Reactive glia as rivals in regulating neuronal survival[J]. Glia, 1993,7(1):102-110
doi: 10.1002/(ISSN)1098-1136
[16] Vorwerk CK, Lipton SA, Zurakowski D, Hyman BT, Sabel BA, Dreyer EB . Chronic low-dose glutamate is toxic to retinal ganglion cells. Toxicity blocked by memantine[J]. Invest Ophthalmol Vis Sci, 1996,37(8):1618-1624
[17] Siliprandi R, Canella R, Carmignoto G, Schiavo N, Zanellato A, Zanoni R, Vantini G . N-methyl-D-aspartate-induced neurotoxicity in the adult rat retina[J]. Vis Neurosci, 1992,8(6):567-573
doi: 10.1017/S0952523800005666
[18] Ahmed FA, Hegazy K, Chaudhary P, Sharma SC . Neuroprotective effect of α2 agonist(brimonidine) on adult rat retinal ganglion cells after increased intraocular pressure[J]. Brain Res, 2001,913(2):133-139
doi: 10.1016/S0006-8993(01)02759-7
[19] Sacca S.Nitric oxide as a mediator of glaucoma pathogenesis[J].Med Sci Monit, 2002, 8(8):LE33-LE34
[20] Aslan M, Cort A, Yucel I . Oxidative and nitrative stress markers in glaucoma[J]. Free Radic Biol Med, 2008,45(4):367-376
doi: 10.1016/j.freeradbiomed.2008.04.026
[21] Siu AW, Leung MC, Ho To C, Siu FK, Ji J, So KF . Total retinal nitric oxide production is increased in intraocular pressure-elevated rats[J]. Exp Eye Res, 2002,75(4):401-406
doi: 10.1006/exer.2002.2029
[22] Neufeld AH, Shareef S, Pena J . Cellular localization of neuronal nitric oxide synthase(NOS-1) in the human and rat retina[J]. J Comp Neurol, 2000,416(2):269-275
doi: 10.1002/(ISSN)1096-9861
[23] Nucci C, Morrone L, Rombolà L, Nisticò R, Piccirilli S, Cerulli L . Multifaceted roles of nitric oxide in the lateral geniculate nucleus: from visual signal transduction to neuronal apoptosis[J]. Toxicol Lett, 2003,139(2-3):163-173
doi: 10.1016/S0378-4274(02)00430-7
[24] Liu B, Neufeld AH . Nitric oxide synthase-2 in human optic nerve head astrocytes induced by elevated pressure in vitro[J]. Arch Ophthalmol, 2001,119(2):240-245
[25] Klein C . Nitric oxide and the other cyclic nucleotide[J]. Cell Signal, 2002,14(6):493-498
doi: 10.1016/S0898-6568(01)00283-2
[26] Groc L, Jackson Hunter T, Jiang H, Bezin L, Koubi D, Corcoran GB, Levine RA . Nitric oxide synthase inhibition during development: effect on apoptotic death of dopamine neurons[J]. Brain Res Dev Brain Res, 2002,138(2):147-153
doi: 10.1016/S0165-3806(02)00464-9
[27] Baltmr A, Duggan J, Nizari S, Salt TE, Cordeiro MF . Neuroprotection in glaucoma — Is there a future role? Exp Eye Res. 2010; 91(5):554-566.
doi: 10.1016/j.exer.2010.08.009
[28] Danesh-Meyer HV . Neuroprotection in glaucoma: recent and future directions[J]. Curr Opin Ophthalmol, 2011,22(2):78-86
doi: 10.1097/ICU.0b013e32834372ec
[29] Cantor LB . Brimonidine in the treatment of glaucoma and ocular hypertension[J]. Ther Clin Risk Manag, 2006,2(4):337-346
doi: 10.2147/tcrm.2006.2.issue-4
[30] Osborne NN . Pathogenesis of ganglion “cell death” in glaucoma and neuroprotection: focus on ganglion cell axonal mitochondria[J]. Prog Brain Res, 2008,173:339-352
doi: 10.1016/S0079-6123(08)01124-2
[31] Ho YS, So KF, Chang RC . Drug discovery from Chinese medicine against neurodegeneration in Alzheimer’s and vascular dementia[J]. Chin Med, 2011,6:15
doi: 10.1186/1749-8546-6-15
[32] Chang RC, So KF . Use of anti-aging herbal medicine, Lycium barbarum, against aging-associated diseases[J]. What do we know so far? Cel Mol Neurobiol, 2008,28(5):643-652
[33] Luo Q, Cai Y, Yan J, Sun M, Corke H . Hypoglycemic and hypolipidemic effects and antioxidant activity of fruit extracts from Lycium barbarum[J]. Life Sci, 2004,76(2):137-149
doi: 10.1016/j.lfs.2004.04.056
[34] Jin M, Huang Q, Zhao K, Shang P . Biological activities and potential health benefit effects of polysaccharides isolated from Lycium barbarum L[J]. Int J Biol Macromol, 2013,54:16-23
doi: 10.1016/j.ijbiomac.2012.11.023
[35] Yu MS, Leung SK, Lai SW, Che CM, Zee SY . Neuroprotective effects of anti-aging oriental medicine Lycium barbarum against β-amyloid peptide neurotoxicity[J]. Exp Gerontol, 2005,40:716-727
doi: 10.1016/j.exger.2005.06.010
[36] Ho YS, Yu MS, Yik SY, So KF, Yuen WH, Chang RCC . Polysaccharides from wolfberry antagonizes glutamate excitotoxicity in rat cortical neurons[J]. Cell Mol Neurobiol, 2009,29(8):1233-1244
doi: 10.1007/s10571-009-9419-x
[37] Chiu K, Zhou Y, Yeung SC, Lok CK, Chan OO, Chang RC, So KF, Chiu JF . Up-regulation of crystallins is involved in the neuroprotective effect of wolfberry on survival of retinal ganglion cells in rat ocular hypertension model[J]. J Cell Biochem, 2010,110(2):311-320
[38] Chan HC, Chang RC , Koon-Ching Ip A, Chiu K, Yuen WH, Zee SY, So KF.Neuroprotective effects of Lycium barbarum Lynn on protecting retinal ganglion cells in an ocular hypertension model of glaucoma[J]. Exp Neurol, 2007,203(1):269-273
doi: 10.1016/j.expneurol.2006.05.031
[39] Li SY, Yeung CM, Yu WY, Chang RC, So KF, Wong D, Lo AC . Lycium barbarum polysaccharides reduce neuronal damage, blood-retinal barrier disruption and oxidative stress in retinal ischemia/reperfusion injury[J]. PLoS One, 2011,6(1):e16380
doi: 10.1371/journal.pone.0016380
[40] Ho YS, So KF, Chang RC . Anti-aging herbal medicine — How and why can they be used in aging-associated neurodegenerative diseases? Ageing Res Rev. 2010; 9(3):354-362.
doi: 10.1016/j.arr.2009.10.001
[41] Chiu K, Chan HC, Yeung SC, Yuen WH, Zee SY, Chang RC, So KF . Modulation of microglia by Wolfberry on the survival of retinal ganglion cells in a rat ocular hypertension model[J]. J Ocul Biol Dis Infor, 2009,2(3):127-136
doi: 10.1007/s12177-009-9035-5
[42] Tezel G . Immune regulation toward immunomodulation for neuroprotection in glaucoma[J]. Curr Opin Pharmacol, 2013,13(1):23-31
doi: 10.1016/j.coph.2012.09.013
[43] Tezel G, Thornton IL, Tong MG, Luo C, Yang X, Cai J, Powell DW, Soltau JB, Liebmann JM, Ritch R . Immunoproteomic analysis of potential serum biomarker candidates in human glaucoma[J]. Invest Ophthalmol Vis Sci, 2012,53(13):8222-8231
doi: 10.1167/iovs.12-10076
[44] Moalem G, Monsonego A, Shani Y, Cohen IR, Schwartz M . Differential T cell response in central and peripheral nerve injury: connection with immune privilege[J]. FASEB J, 1999,13(10):1207-1217
doi: 10.1096/fasebj.13.10.1207
[45] Barouch R, Schwartz M . Autoreactive T cells induce neurotrophin production by immune and neural cells in injured rat optic nerve: implications for protective autoimmunity[J]. FASEB J, 2002,16(10):1304-1306
doi: 10.1096/fj.01-0467fje
[46] Bosco A, Steele MR, Vetter ML . Early microglia activation in a mouse model of chronic glaucoma[J]. J Comp Neurol, 2011,519(4):599-620
doi: 10.1002/cne.22516
[47] Gan L, Zhang SH, Liu Q, Xu HB . A polysaccharide-protein complex from Lycium barbarum upregulates cytokine expression in human peripheral blood mononuclear cells[J]. Eur J Pharmacol, 2003,471(3):217-222
doi: 10.1016/S0014-2999(03)01827-2
[48] Yu MS, Ho YS, So KF, Yuen WH, Chang RC . Cytoprotective effects of Lycium barbarum against reducing stress on endoplasmic reticulum[J]. Int J Mol Med, 2006,17(6):1157-1161
[49] Krishnamoorthy RR, Rao VR, Dauphin R, Prasanna G, Johnson C, Yorio T . Role of the ETB receptor in retinal ganglion cell death in glaucoma[J]. Can J Physiol Pharmacol, 2008,86(6):380-393
doi: 10.1139/Y08-040
[50] Mi XS, Chiu K, Van G, Leung JWC, Lo AC, Chung SK, Chang RC, So KF . Effect of Lycium barbarum polysaccharides on the expression of endothelin-1 and its receptors in an ocular hypertension model of rat glaucoma[J]. Neural Regen Res, 2012,7(9):645-651
[51] Mi XS, Feng Q, Lo AC, Chang RC, Lin B, Chung SK, So KF . Protection of retinal ganglion cells and retinal vasculature by Lycium barbarum polysaccharides in a mouse model of acute ocular hypertension[J]. PLoS One, 2012,7(10):e45469
doi: 10.1371/journal.pone.0045469
[52] Chen DF, Cho KS. Optic neuropathy and ganglion cell degeneration in glaucoma: mechanisms and therapeutic strategies. In: Tombran-Tink J, Barnstable CJ, Shields MB.Mechanisms of the glaucomas: disease processes and therapeutic modalities[M]. Totowa: Humana Press, 2008, 393-423
[53] Peng Y, Ma C, Li Y, Leung KS, Jiang ZH, Zhao Z . Quantification of zeaxanthin dipalmitate and total carotenoids in Lycium fruits(Fructus Lycii)[J]. Plant Foods Hum Nutr, 2005,60(4):161-164
doi: 10.1007/s11130-005-9550-5
[54] Benzie IF, Chung WY, Wang J, Richelle M, Bucheli P . Enhanced bioavailability of zeaxanthin in a milk-based formulation of wolfberry(Gou Qi Zi; Fructus barbarum L.)[J]. Br J Nutr, 2006,96(1):154-160
doi: 10.1079/BJN20061796
[55] Llansola M, Erceg S, Hernandez-Viadel M, Felipo V . Prevention of ammonia and glutamate neurotoxicity by carnitine: molecular mechanisms[J]. Metab Brain Dis, 2002,17(4):389-397
doi: 10.1023/A:1021922305036
[56] Birks J, Grimley Evans J.Ginkgo biloba for cognitive impairment and dementia[J].Cochrane Database Syst Rev , 2009,( 1):CD003120
[57] DeFeudis FV, Drieu K . Ginkgo biloba extract(EGb 761) and CNS functions: basic studies and clinical applications[J]. Curr Drug Targets, 2000,1(1):25-58
doi: 10.2174/1389450003349380
[58] Chung SY, Cheng FC, Lee MS, Lin JY, Lin MC, Wang MF . Ginkgo biloba leaf extract(EGb761) combined with neuroprotective agents reduces the infarct volumes of gerbil ischemic brain[J]. Am J Chin Med, 2006,34(5):803-817
doi: 10.1142/S0192415X06004302
[59] Chung HS, Harris A, Kristinsson JK, Ciulla TA, Kagemann C, Ritch R . Ginkgo biloba extract increases ocular blood flow velocity[J]. J Ocul Pharmacol Ther, 1999,15(3):233-240
doi: 10.1089/jop.1999.15.233
[60] Park JW, Kwon HJ, Chung WS, Kim CY, Seong GJ . Short-term effects of Ginkgo biloba extract on peripapillary retinal blood flow in normal tension glaucoma[J]. Korean J Ophthalmol, 2011,25(5):323-328
doi: 10.3341/kjo.2011.25.5.323
[61] Domoráková I, Mechírová E, Danková M, Danielisová V, Burda J . Effect of antioxidant treatment in global ischemia and ischemic postconditioning in the rat hippocampus[J]. Cell Mol Neurobiol, 2009,29(6-7):837-844
doi: 10.1007/s10571-009-9365-7
[62] Nada SE, Shah ZA . Preconditioning with Ginkgo biloba(EGb 761?) provides neuroprotection through HO1 and CRMP2[J]. Neurobiol Dis, 2012,46(1):180-189
doi: 10.1016/j.nbd.2012.01.006
[63] Saleem S, Zhuang H, Biswal S, Christen Y, Doré S . Ginkgo biloba extract neuroprotective action is dependent on heme oxygenase 1 in ischemic reperfusion brain injury[J]. Stroke, 2008,39(12):3389-3396
doi: 10.1161/STROKEAHA.108.523480
[64] Shah ZA, Nada SE, Doré S . Heme oxygenase 1, beneficial role in permanent ischemic stroke and in Gingko biloba(EGb 761) neuroprotection[J]. Neuroscience, 2011,180:248-255
doi: 10.1016/j.neuroscience.2011.02.031
[65] Mdzinarishvili A, Sumbria R, Lang D, Klein J . Ginkgo extract EGb761 confers neuroprotection by reduction of glutamate release in ischemic brain[J]. J Pharm Pharm Sci, 2012,15(1):94-102
doi: 10.18433/J3PS37
[66] Flammer J, Mozaffarieh M . What is the present pathogenetic concept of glaucomatous optic neuropathy? Surv Ophthalmol. 2007; 52(Suppl 2):S162-S173.
doi: 10.1016/j.survophthal.2007.08.012
[67] Koh PO . Gingko biloba extract(EGb 761) prevents increase of Bad-Bcl-XL interaction following cerebral ischemia[J]. Am J Chin Med, 2009,37(5):867-876
doi: 10.1142/S0192415X0900734X
[68] Smith JV, Burdick AJ, Golik P, Khan I, Wallace D, Luo Y . Anti-apoptotic properties of Ginkgo biloba extract EGb 761 in differentiated PC12 cells[J]. Cell Mol Biol (Noisy-le-grand), 2002,48(6):699-707
[69] Khoury R, Cross JM, Girkin CA, Owsley C , McGwin G Jr.The association between self-reported glaucoma and Ginkgo biloba use[J]. J Glaucoma, 2009,18(7):543-545
doi: 10.1097/IJG.0b013e318193c44a
[70] Hirooka K, Tokuda M, Miyamoto O, Itano T, Baba T, Shiraga F . The Ginkgo biloba extract(EGb 761) provides a neuroprotective effect on retinal ganglion cells in a rat model of chronic glaucoma[J]. Curr Eye Res, 2004,28(3):153-157
doi: 10.1076/ceyr.
[1] Sherman Gu, Arthur Yin Fan. Controversial conclusions from two randomized controlled trials for acupuncture's effects on polycystic ovary syndrome or in vitro fertilization support. Journal of Integrative Medicine, 2020, 18(2): 89-91.
[2] Xue-qing Yu, Shu-guang Yang, Yang Xie, Jian-sheng Li. Traditional Chinese medicine in the treatment of idiopathic pulmonary fibrosis based on syndrome differentiation: Study protocol of exploratory trial. Journal of Integrative Medicine, 2020, 18(2): 163-168.
[3] Chang-quan Ling. Traditional Chinese medicine is a resource for drug discovery against 2019 novel coronavirus (SARS-CoV-2). Journal of Integrative Medicine, 2020, 18(2): 87-88.
[4] Dona Nirmani Ann Wijewickrama Samarakoon, Deepthi Inoka Uluwaduge, Malith Aravinda Siriwardhene. Mechanisms of action of Sri Lankan herbal medicines used in the treatment of diabetes: A review. Journal of Integrative Medicine, 2020, 18(1): 13-20.
[5] Wen Qiang Lee, Jeremy Teoh, Pei Zheng Kenneth Lee, Zhi Xiong Gerard Low, Xueling Sim, Foong Fong Mary Chong, Norbert Ludwig Wagner. Factors influencing communication of traditional Chinese medicine use between patients and doctors: a multisite cross-sectional study. Journal of Integrative Medicine, 2019, 17(6): 396-403.
[6] Lena Grönblom Lundström, Ulrika Aasa, Yan Zhang, Tobias Sundberg. Health care in light of different theories of health—A proposed framework for integrating a social humanistic perspective into health care. Journal of Integrative Medicine, 2019, 17(5): 321-327.
[7] Mikhail Teppone. Medicine has always been “Modern” and “Scientific” from ancient times to the present day. Journal of Integrative Medicine, 2019, 17(4): 229-237.
[8] Charles Dalcanale Tesser, Ari Ojeda Ocampo Moré, Melissa Costa Santos, Emiliana Domingues Cunha da Silva, Fátima Terezinha Pelachini Farias, Lúcio José Botelho. Auriculotherapy in primary health care: A large-scale educational experience in Brazil. Journal of Integrative Medicine, 2019, 17(4): 302-309.
[9] Rachael Farrington, Ian F.Musgrave, Roger W.Byard. Evidence for the efficacy and safety of herbal weight loss preparations. Journal of Integrative Medicine, 2019, 17(2): 87-92.
[10] Fung-Kei Cheng. An overview of the contribution of acupuncture to thyroid disorders. Journal of Integrative Medicine, 2018, 16(6): 375-383.
[11] Jia Xu, Fu-qing Zhang, Jian Pei, Jun Ji . Acupuncture for migraine without aura: A systematic review and meta-analysis. Journal of Integrative Medicine, 2018, 16(5): 312-321.
[12] Chang-quan Ling, Jia Fan, Hong-sheng Lin, Feng Shen, Zhen-ye Xu, Li-zhu Lin, Shu-kui Qin, Wei-ping Zhou, Xiao-feng Zhai, Bai Li, Qing-hui Zhou, on behalf of the Chinese Integrative Therapy of Primary Liver Cancer Working Group. Clinical practice guidelines for the treatment of primary liver cancer with integrative traditional Chinese and Western medicine. Journal of Integrative Medicine, 2018, 16(4): 236-248.
[13] Wen-jie Xu, Ling-tai Wang, Zhi-ping Zhao, Li-ming Zhu, Liang-hua Zu, Qi Zhang, Dan-bo Dou. Prospects of a comprehensive evaluation system for traditional Chinese medicine services. Journal of Integrative Medicine, 2017, 15(6): 426-432.
[14] Naseem Akhtar Qureshi, Gazzaffi Ibrahim Ali, Tamer Shaban Abushanab, Ahmed Tawfik El-Olemy, Meshari Saleh Alqaed, Ibrahim S. El-Subai, Abdullah M.N. Al-Bedah. History of cupping (Hijama): A narrative review of literature. Journal of Integrative Medicine, 2017, 15(3): 172-181.
[15] Tom Fleischer, Tung-Ti Chang, Hung-Rong Yen. Post-hematopoietic stem cell transplantation in patients with hematologic disorders: Chinese herbal medicine for an unmet need. Journal of Integrative Medicine, 2016, 14(5): 322-335.
Full text



[1] Wei-xiong Liang. Problems-solving strategies in clinical treatment guideline for traditional Chinese medicine and integrative medicine. Journal of Chinese Integrative Medicine, 2008, 6(1): 1-4
[2] Zhao-guo Li. Discussion on English translation of commonly used sentences in traditional Chinese medicine: part one. Journal of Chinese Integrative Medicine, 2008, 6(1): 107-110
[3] Jun Hu, Jian-ping Liu. Non-invasive physical treatments for chronic/recurrent headache. Journal of Chinese Integrative Medicine, 2008, 6(1): 31
[4] Yi-ting He, Qing-lin Zha, Jian-ping Yu, Yong Tan, Cheng Lu, Ai-ping Lv. Principal factor analysis of symptoms of rheumatoid arthritis and their correlations with efficacy of traditional Chinese medicine and Western medicine. Journal of Chinese Integrative Medicine, 2008, 6(1): 32-36
[5] Dong Yang, Yong-ping Du, Qing Shen, Wei Chen, Yan Yu, Guang-lei Chen. Expression of alpha-smooth muscle actin in renal tubulointerstitium in patients with kidney collateral stasis. Journal of Chinese Integrative Medicine, 2008, 6(1): 41-44
[6] Zhi-chun Jin. Problems in establishing clinical guideline for integrated traditional Chinese and Western medicine. Journal of Chinese Integrative Medicine, 2008, 6(1): 5-8
[7] SUN Ming-yu, ZUO Jian, DUAN Ji-feng, HAN Jun, FAN Shi-ming, ZHANG Wei, ZHU Li-fang, YAO Ming-hui. Antitumor activities of kushen flavonoids in vivo and in vitro. Journal of Chinese Integrative Medicine, 2008, 6(1): 51-59
[8] Min Cheng, Qiong Feng, Shu-wen Qian, Hui Gao, Cui-qing Zhu. Preliminary assay of p-amyloid binding elements in heart-beneficial recipe. Journal of Chinese Integrative Medicine, 2008, 6(1): 68-72
[9] Hai-feng Wei, Bai-liu Ya, Ling Zhao, Cui-fei Ye, Li Zhang, Lin Li. Evaluation of tongue manifestation of blood stasis syndrome and its relationship with blood rheological disorder in a rat model of transient brain ischemia. Journal of Chinese Integrative Medicine, 2008, 6(1): 73-76
[10] A-gao Zhou, Yong Zhang, Gang Kui, De-Yun Kong, Hai-liang Ge, Qiu-hua Ren, Jia-rong Dong, Sheng Hong, Xu-ming Mao, Yin Wang, Hui-zheng Zhang, Shu-jun Wang. Influence of traditional Chinese compound recipes with different efficacy on body weight, tumor weight and immune function in H22 cancer-bearing mice. Journal of Chinese Integrative Medicine, 2008, 6(1): 77-82